-
公开(公告)号：US20150246020A1
公开(公告)日：2015-09-03
申请号：US14584177
申请日：2014-12-29
Applicant: EPICENTRX, INC. , ALLIANT TECHSYSTEMS INC.
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: A61K31/397
CPC classification number: A61K31/397 , A61K9/0019 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US08927527B2
公开(公告)日：2015-01-06
申请号：US13655618
申请日：2012-10-19
Applicant: RadioRx, Inc. , Alliant Techsystems Inc.
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: C07D205/04
CPC classification number: A61K31/397 , A61K9/0019 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US20130123216A1
公开(公告)日：2013-05-16
申请号：US13655618
申请日：2012-10-19
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: C07D205/04
CPC classification number: A61K31/397 , A61K9/0019 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US20200046682A1
公开(公告)日：2020-02-13
申请号：US16353047
申请日：2019-03-14
Applicant: EpicentRx, Inc. , Northrop Grumman Innovation Systems, Inc.
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: A61K31/397 , A61K9/00 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US11925617B2
公开(公告)日：2024-03-12
申请号：US17186724
申请日：2021-02-26
Applicant: EpicentRx, Inc. , Northrop Grumman Systems Corporation
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: A61K31/397 , A61K9/00 , A61N5/10 , A61P9/00 , A61P29/00 , A61P35/00 , A61P35/02 , A61P37/06 , A61P43/00 , C07D205/02 , C07D205/04
CPC classification number: A61K31/397 , A61K9/0019 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
Patent Agency Ranking
公开(公告)号：US20160199346A1
公开(公告)日：2016-07-14
申请号：US14965062
申请日：2015-12-10
Applicant: EpicentRx, Inc. , Orbital ATK, Inc.
Inventor： MARK D. BEDNARSKI , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: A61K31/397 , A61N5/10 , A61K9/00
CPC classification number: A61K31/397 , A61K9/0019 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US20220016077A1
公开(公告)日：2022-01-20
申请号：US17186724
申请日：2021-02-26
Applicant: EpicentRx, Inc. , Northrop Grumman Systems Corporation
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: A61K31/397 , A61K9/00 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US10149832B2
公开(公告)日：2018-12-11
申请号：US14965062
申请日：2015-12-10
Applicant: EpicentRx, Inc. , Orbital ATK, Inc.
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: C07D205/04 , A61N5/10 , A61K31/397 , A61K9/00
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US20180085346A1
公开(公告)日：2018-03-29
申请号：US15669403
申请日：2017-08-04
Applicant: EpicentRx, Inc. , Orbital ATK, Inc.
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: A61K31/397 , A61K9/00 , A61N5/10 , C07D205/04
CPC classification number: A61K31/397 , A61K9/0019 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
公开(公告)号：US09226915B2
公开(公告)日：2016-01-05
申请号：US14584177
申请日：2014-12-29
Applicant: EpicentRx, Inc. , Orbital ATK, Inc.
Inventor： Mark D. Bednarski , Susan Knox , Louis Cannizzo , Kirstin Warner , Robert Wardle , Stephen Velarde , Shoucheng Ning
IPC: C07D205/04 , A61K31/397
CPC classification number: A61K31/397 , A61K9/0019 , A61N5/10 , C07D205/04
Abstract: The present invention provides cyclic nitro compound, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.019 seconds)
